Evidence Archives

SABCS 2019: FLEX African American Clinical Data
Gallery
SABCS 2019: FLEX African American Clinical Data

Evidence, Other, Racial Disparities

SABCS 2019: FLEX African American Clinical Data

AUTHORS: Raquel Nunes, Dipali Sharma, Lisa E. Blumencranz, Heather M. Read More

kevin2024-03-25T08:31:24-07:00December 12th, 2019|Evidence, Other, Racial Disparities|

SABCS 2019: PROMIS Clinical Risk
Gallery
SABCS 2019: PROMIS Clinical Risk

Adjuvant, Evidence, PROMIS

SABCS 2019: PROMIS Clinical Risk

AUTHORS: Michaela Tsai, Hatem Soliman, Shelly Lo, Rubina Qamar, Raye Read More

kevin2024-03-25T08:32:19-07:00December 12th, 2019|Adjuvant, Evidence, PROMIS|

ESMO Sept 30 Successful launch of the MammaPrint and BluePrint NGS
Gallery
ESMO Sept 30 Successful launch of the MammaPrint and BluePrint NGS

Evidence, Other, Validation

ESMO Sept 30 Successful launch of the MammaPrint and BluePrint NGS

AUTHORS: Leonie JMJ Delahaye, Anke T Witteveen, Mireille HJ Snel1, Read More

kevin2024-03-25T08:33:12-07:00September 30th, 2019|Evidence, Other, Validation|

ESMO Sept 29 Unravelling the biological characteristics of MammaPrint
Gallery
ESMO Sept 29 Unravelling the biological characteristics of MammaPrint

Evidence, Other

ESMO Sept 29 Unravelling the biological characteristics of MammaPrint

AUTHORS Rajith Bhaskaran, Christian J Griffioen, Diedrik Wehkamp, Lorenza Mittempergher Read More

kevin2024-03-25T08:34:50-07:00September 29th, 2019|Evidence, Other|

Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.
Gallery
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.

Evidence, MammaPrint, Other, Validation

Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.

PUBLICATION: Transl Oncol. 2019 Sep 9;12(12):1557-1565. doi: 10.1016/j.tranon.2019.08.008. AUTHORS: Slembrouck Read More

kevin2024-03-25T08:36:04-07:00September 9th, 2019|Evidence, MammaPrint, Other, Validation|

MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology
Gallery
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology

BluePrint, Evidence, MammaPrint, Other, Validation

MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology

PUBLICATION: Journal of Molecular Diagnostics September 2019 Volume 21, Issue Read More

kevin2024-03-25T08:36:57-07:00September 1st, 2019|BluePrint, Evidence, MammaPrint, Other, Validation|

Prospective Validation of a Genomic Assay in Breast Cancer: The 70-Gene MammaPrint Assay and the MINDACT Trial
Gallery
Prospective Validation of a Genomic Assay in Breast Cancer: The 70-Gene MammaPrint Assay and the MINDACT Trial

Adjuvant, Evidence, MammaPrint, MINDACT, Other, Validation

Prospective Validation of a Genomic Assay in Breast Cancer: The 70-Gene MammaPrint Assay and the MINDACT Trial

PUBLICATION: Acta Medica Academica. Volume 48 (2) August 2019 AUTHOR: Read More

kevin2024-03-25T08:46:25-07:00August 2nd, 2019|Adjuvant, Evidence, MammaPrint, MINDACT, Other, Validation|

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline
Gallery
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline

Adjuvant, Evidence, MINDACT

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline

PUBLICATION: Journal of Clinical Oncology 37, no. 22 (August 01, Read More

kevin2024-03-25T08:47:41-07:00August 1st, 2019|Adjuvant, Evidence, MINDACT|

The Changing Role of Gene-Expression Profiling in the Era of Deescalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
Gallery
The Changing Role of Gene-Expression Profiling in the Era of Deescalating Adjuvant Chemotherapy in Early-Stage Breast Cancer

Adjuvant, Evidence

The Changing Role of Gene-Expression Profiling in the Era of Deescalating Adjuvant Chemotherapy in Early-Stage Breast Cancer

PUBLICATION: Ann Surg Oncol (2019) 26: 3495. https://doi.org/10.1245/s10434-019-07511-8. AUTHORS: J.E.C. Read More

kevin2024-03-25T08:50:09-07:00June 17th, 2019|Adjuvant, Evidence|

ASCO June 5 2019: Race and response to neoadjuvant chemotherapy
Gallery
ASCO June 5 2019: Race and response to neoadjuvant chemotherapy

Evidence, MammaPrint, NBRST, Neoadjuvant, Other, Racial Disparities

ASCO June 5 2019: Race and response to neoadjuvant chemotherapy

AUTHORS: Raquel Nunes, Femke de Snoo, Lisette Stork-Sloots, Tina Treece, Read More

kevin2024-03-25T08:51:00-07:00June 5th, 2019|Evidence, MammaPrint, NBRST, Neoadjuvant, Other, Racial Disparities|